Rare patients with germline genetic syndromes, affecting SCN1A (Barba et al., 2014) and PCDH19 (Kurian et al., 2018), have been described as having FCD type II on histopathological assessment. This evidence concerns the gene SCN1A and isolated focal cortical dysplasia type II.